Radiology, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Neurosurgery. 2010 Jun;66(6):1128-33; discussion 1133. doi: 10.1227/01.NEU.0000367998.33743.D6.
To evaluate clinical presentation, safety, techniques, clinical and angiographic outcomes, and prognostic factors of coiling for remnant/recurred aneurysm after clipping.
Twenty-four consecutive patients (11 men and 13 women; mean age, 52 years) with 24 recurred/remnant aneurysms after clipping underwent coil embolization between September 2000 and December 2008. Clinical presentations of remnant/recurred aneurysms, safety, techniques, clinical and angiographic outcomes, and prognostic factors of coil embolization were retrospectively evaluated.
Twenty-two aneurysms initially presented with subarachnoid hemorrhage and the other two, with mass effect. Eight aneurysms presented with rebleeding and 16 aneurysms were found on follow-up CT angiogram (n = 12) or catheter angiogram (n = 4). The interval between clipping and coiling ranged from 8 days to 114 months (mean, 31 months). Twelve were treated by using single-catheter, 6 by stent-assisted, 4 by multicatheter, 1 by both balloon- and catheter-assisted, and 1 by balloon-in-stent technique. Immediate postembolization angiogram revealed complete obliteration (n = 19) or residual neck (n = 5). Procedure-related permanent morbidity and mortality rates were 4.2% (1 of 24) and 0%, respectively. There was no rebleeding during clinical follow-up for 3 to 82 months (mean, 24 months). Presentation with rupture after clipping was the only significant predictor of poor outcome (P < .05).
Coiling seems to be a safe and effective retreatment option for remnant/ recurred aneurysm after clipping. Presentation with rupture after clipping is the only predictor of poor outcome. For routine/regular follow-up after clipping, CT angiography may be the imaging modality advisable for detection of remnant/recurred aneurysm.
评估夹闭术后残留/复发动脉瘤的临床表现、安全性、技术、临床和血管造影结果以及预后因素。
2000 年 9 月至 2008 年 12 月,对 24 例夹闭术后复发/残留动脉瘤的 24 例患者(11 例男性,13 例女性;平均年龄 52 岁)进行了线圈栓塞治疗。回顾性评估残留/复发动脉瘤的临床表现、安全性、技术、临床和血管造影结果以及线圈栓塞的预后因素。
22 例动脉瘤首次表现为蛛网膜下腔出血,另外 2 例表现为占位效应。8 例动脉瘤再次出血,16 例在随访 CT 血管造影(n = 12)或导管血管造影(n = 4)中发现。夹闭与线圈栓塞之间的时间间隔为 8 天至 114 个月(平均 31 个月)。12 例采用单导管治疗,6 例采用支架辅助治疗,4 例采用多导管治疗,1 例采用球囊和导管辅助治疗,1 例采用球囊内支架技术。即刻栓塞后血管造影显示完全闭塞(n = 19)或残留瘤颈(n = 5)。与手术相关的永久性发病率和死亡率分别为 4.2%(24 例中的 1 例)和 0%。在 3 至 82 个月(平均 24 个月)的临床随访期间无再出血。夹闭后破裂是预后不良的唯一显著预测因素(P <.05)。
线圈栓塞似乎是夹闭术后残留/复发动脉瘤的一种安全有效的治疗选择。夹闭后破裂是预后不良的唯一预测因素。对于夹闭后的常规/定期随访,CT 血管造影可能是检测残留/复发动脉瘤的首选影像学方式。